Blog
Why the 'Gold Standard' of clinical trials fails the individual, and why true precision health treats you as a single-subject experiment.

In modern science, the Randomized Controlled Trial (RCT) is worshipped as the "Gold Standard." To prove a drug works, you give it to 1,000 people. If 600 improve and 400 don't, the drug is deemed "effective."
That's great for the pharmaceutical company. They can sell it to everyone. But what if you are one of the 400?
For you, that "effective" drug is 0% effective. In fact, it might be toxic.
Traditional Evidence-Based Medicine (EBM) relies on aggregates. It smoothes out the data to find the "average patient."
But biology doesn't work on averages. Biology works on specificity.
At MorphoLab, we subscribe to a different scientific philosophy: The N=1 Experiment.
In an N=1 trial, the sample size is one. You. We don't care what works for "most people." We care what works for this specific biological system, with this specific history, in this specific environment.
This philosophy is the foundation of everything we do, and everything we will do.
Today, it's about custom biomechanics. Tomorrow, it will be about Precision Supplementation. Why take a multivitamin formulated for the "average adult male" when we can analyze your blood work and print a daily stack that contains exactly—and only—what your body lacks?
The future of health isn't finding the cure for the masses. It's finding the optimization for the individual. You are not a statistic. You are a sample size of one.